World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT00289094
Date of registration: 07/02/2006
Primary sponsor: DePuy Orthopaedics
Public title: Randomized Fixed Bearing vs Mobile Bearing Cruciate Retaining TKA
Scientific title: Multi-center, Prospective, Clinical Evaluation of the PFC Sigma Rotating Platform Cruciate Retaining Versus PFC Sigma Cruciate Retaining Knee Primary Cases
Date of first enrolment: May 2001
Target sample size: 99
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00289094
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment  
Countries of recruitment
Contacts
Name:   Tammy L O'Dell, EMT, CCRA, CCRC
Address: 
Telephone:
Email:
Affiliation:  DePuy Orthopaedics
Key inclusion & exclusion criteria

Inclusion Criteria:

- Osteoarthritis

- Rheumatoid Arthritis

- Other inflammatory arthritis

- Avascular necrosis of bone

Exclusion Criteria:

- Prior ipsilateral TKA

- Metabolic disorders

- Joint replacement due to autoimmune disorders



Age minimum: 18 Years
Age maximum: 75 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Avascular Necrosis of Bone
Osteoarthritis
Rheumatoid Arthritis
Intervention(s)
Device: Total Knee Arthroplasty
Device: Total knee replacement
Primary Outcome(s)
Knee Society Scores [Time Frame: Pre-operative, 6 and 12 months and annually thereafter for at least 5 years.]
Secondary Outcome(s)
Complications/Revisions [Time Frame: On-going to end of study.]
Medical Imaging [Time Frame: Pre-operative, 6 and 12 months and annually thereafter for at least 5 years.]
SF-12 Patient Outcomes [Time Frame: Pre-operative, 6 and 12 months and annually thereafter for at least 5 years.]
Secondary ID(s)
SRP-2
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history